Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Capital Expenditures (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Capital Expenditures for 9 consecutive years, with $58.9 million as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 12.53% year-over-year to $58.9 million; the TTM value through Mar 2026 reached $235.8 million, up 991.29%, while the annual FY2025 figure was $229.2 million, 952.26% up from the prior year.
  • Capital Expenditures hit $58.9 million in Q1 2026 for Select Medical Holdings, roughly flat from $59.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $64.7 million in Q2 2025 and bottomed at -$137.0 million in Q4 2024.
  • Average Capital Expenditures over 5 years is $42.9 million, with a median of $53.1 million recorded in 2025.
  • Year-over-year, Capital Expenditures tumbled 326.0% in 2024 and then skyrocketed 143.15% in 2025.
  • Select Medical Holdings' Capital Expenditures stood at $55.3 million in 2022, then increased by 9.68% to $60.6 million in 2023, then crashed by 326.0% to -$137.0 million in 2024, then surged by 143.15% to $59.1 million in 2025, then dropped by 0.34% to $58.9 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $58.9 million, $59.1 million, and $53.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.